Employing the R2 genomics platform to query the 99 DUBs for their association with the GO category of Regulation of the ERAD pathway, we identified 3 DUB genes in this category as differentially expressed in the glioma dataset: USP14, USP19, and USP25 (Table 3). This evidence concerns the gene USP19 and central nervous system cancer.